These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 15695072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential regulation of the expression of contextual freezing and fear-potentiated startle by 5-HT mechanisms of the median raphe nucleus.
    Silva RC, Gárgaro AC, Brandão ML.
    Behav Brain Res; 2004 May 05; 151(1-2):93-101. PubMed ID: 15084425
    [Abstract] [Full Text] [Related]

  • 3. Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning.
    Santos JM, Martinez RC, Brandão ML.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):121-8. PubMed ID: 16831418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimization of a contextual conditioning protocol for rats using combined measurements of startle amplitude and freezing: the effects of shock intensity and different types of conditioning.
    Luyten L, Vansteenwegen D, van Kuyck K, Deckers D, Nuttin B.
    J Neurosci Methods; 2011 Jan 15; 194(2):305-11. PubMed ID: 21087634
    [Abstract] [Full Text] [Related]

  • 6. Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning.
    Borelli KG, Gárgaro AC, dos Santos JM, Brandão ML.
    Neurosci Lett; 2005 Oct 21; 387(2):105-10. PubMed ID: 16085359
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Contextual fear-potentiated startle conditioning in humans: replication and extension.
    Ameli R, Ip C, Grillon C.
    Psychophysiology; 2001 May 21; 38(3):383-90. PubMed ID: 11352126
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of lorazepam on fear-potentiated startle responses in man.
    Graham SJ, Scaife JC, Langley RW, Bradshaw CM, Szabadi E, Xi L, Crumley T, Calder N, Gottesdiener K, Wagner JA.
    J Psychopharmacol; 2005 May 21; 19(3):249-58. PubMed ID: 15888510
    [Abstract] [Full Text] [Related]

  • 15. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM, Grillon C, Böcker KB, Brack AA, Morgan CA, Kenemans JL, Verbaten MN.
    Psychopharmacology (Berl); 2002 May 21; 161(3):233-47. PubMed ID: 12021826
    [Abstract] [Full Text] [Related]

  • 16. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
    Walker DL, Davis M.
    Psychopharmacology (Berl); 2002 Nov 21; 164(3):318-28. PubMed ID: 12424556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological and anatomical analysis of fear conditioning.
    Davis M.
    NIDA Res Monogr; 1990 Nov 21; 97():126-62. PubMed ID: 2247135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.